Thursday, February 9, 2012 Last update: 4:33 PM
The Best of U.S. Company Technology News

EntreMed, Inc.

print this company - email to a friend - join our eNewsletter
News articles for EntreMed, Inc.:

Monday, February 6, 2012

  • EntreMed Completes Strategic Financing
    ROCKVILLE, Md., Feb. 6, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012. The Company expects to receive ... read more
  • Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors
    ROCKVILLE, Md., Feb. 6, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that Wei-Wu He, Ph.D has joined the Board of Directors as Executive Chairman and Tak W. Mak, Ph.D has joined as a member ... read more

Monday, November 14, 2011

  • EntreMed Reports Third Quarter 2011 Financial Results
    ROCKVILLE, Md., Nov. 14, 2011 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and nine-month periods ending September 30, 2011. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO ) EntreMed reported a net loss for the third quarter of ... read more

Monday, October 3, 2011

Monday, August 15, 2011

  • EntreMed Reports Second Quarter 2011 Financial Results
    ROCKVILLE, Md., Aug. 15, 2011 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and six-month periods ending June 30, 2011. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO ) EntreMed reported a net loss for the second quarter of 2011 ... read more